Last reviewed · How we verify
Infection by Trichomonas
Approved treatments
- Metro I.V. In Plastic Container · Baxter
- Tindamax · Mission Pharma
Tindamax works by damaging the DNA of susceptible microorganisms, ultimately leading to their death. - Atrican
African works by targeting the parasite that causes Trichomonas infections. - Trichonat
Hachimycin works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death. - Solosec · Evofem Inc
Solosec works by entering susceptible microorganisms and disrupting their DNA, ultimately leading to cell death. - Metronidazol · University of Oslo
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Infection by Trichomonas patent landscape — cliff calendar, originator estates, attackable patents
- Infection by Trichomonas treatment landscape brief
- Infection by Trichomonas treatment updates RSS
Frequently asked questions about Infection by Trichomonas
What drugs treat Infection by Trichomonas?
Tracked treatments include Metro I.V. In Plastic Container, Tindamax, Atrican, Trichonat, Solosec, Metronidazol.
What is the treatment for Infection by Trichomonas?
Standard treatment for Infection by Trichomonas includes Metro I.V. In Plastic Container, Tindamax, Atrican, Trichonat, Solosec. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Infection by Trichomonas patent cliff · Infection by Trichomonas CI report
- Treatment: Metro I.V. In Plastic Container · Baxter
- Treatment: Tindamax · Mission Pharma
- Treatment: Atrican
- Treatment: Trichonat
- Treatment: Solosec · Evofem Inc
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing